Advanced Customized Technologies for Intact Vision in Ageing
The proposed DN “Advanced Customized Technologies for Intact Vision in Ageing” (ACTIVA) provides an international, interdisciplinary platform to train young scientists at the interface of physics and medicine to study unresolved q...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
DPI2016-75272-R
TECNOLOGIAS FOTONICAS APLICADAS PARA LA COMPENSACION Y DIAGN...
182K€
Cerrado
OBERON
Opto Biomechanical Eye Research Network
4M€
Cerrado
FIS2013-42204-R
EVALUACION, IMPACTO Y MEJORA DE LA CALIDAD VISUAL EN SITUACI...
51K€
Cerrado
HELMHOLTZ
Holistic evaluation of light and multiwave applications to h...
12M€
Cerrado
PID2019-107058RB-I00
ENVEJECIMIENTO DEL SISTEMA OPTICO DEL OJO:DESARROLLO DE INST...
33K€
Cerrado
FIS2010-14926
TECNOLOGIAS FOTONICAS PARA EL ESTUDIO DEL OJO Y LA VISION
448K€
Cerrado
Información proyecto ACTIVA
Duración del proyecto: 47 meses
Fecha Inicio: 2023-09-01
Fecha Fin: 2027-08-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The proposed DN “Advanced Customized Technologies for Intact Vision in Ageing” (ACTIVA) provides an international, interdisciplinary platform to train young scientists at the interface of physics and medicine to study unresolved questions and develop novel techniques to facilitate intact, or even improved, visual function in the elderly population. Good vision throughout life is a key factor both on a personal level and socioeconomically and has particular pertinence to the ageing population of Europe.ACTIVA is a joint initiative to develop new optical technologies that will facilitate good vision throughout life. Within the project, 9 young researchers will be trained in new optical technologies to diagnose and compensate for different aspects of the normal ageing of the eye as well as the most common age-related ocular conditions. The novel vision enabling techniques, to be developed in this DN, will focus on facilitating the functionality of both near and far vision. Furthermore, early diagnosis of ocular diseases is essential to offer timely treatment and reduce the risk of vision loss. The novel diagnosis technologies, to be developed in this DN, will focus on early detection of pathological changes in visual function. The consortium combines the expertise of three academic partners with excellent research and teaching records and two fully integrated private sector partners. Furthermore, the consortium will be counselled by a scientifically accomplished External Advisory Board. Close collaborations and multi-site training activities will ensure to provide the young researchers with a vast network and interdisciplinary research experience. ACTIVA will be recognized worldwide as a major contribution to the ageing challenge and the social investment of the European Commission in active ageing.